Recording Available of SLC Webinar: Industry Perspective on Biomarkers

A recording is now available of the Scientific Liaison Coalition (SLC) Industry Perspective on Biomarkers Webinar that aired live on October 28, 2015.  

This webinar features Eugene E. Marcantonio, MD, PhD, Associate Vice President, Translational Pharmacology at Merck Research Laboratories (MRL) and provides an overview of how biomarkers are used in clinical trials in the pharmaceutical industry. Most of the discussion focuses on fit for purpose biomarkers that have been developed in order to make critical decisions in early drug development. Dr. Marcantonio joined MRL in 2007 and has been involved in the early clinical development of a number of compounds in multiple disease areas and now is the lead for Infectious Diseases and Vaccines as well as for Immunology. 

The recording of this webinar is posted on BDR Connection in the Educational Webinars File file, which houses several recordings of past webinars, including previous SLC Biomarker webinars.

The mission of the SLC is “improving the ability of societies to partner with other domestic and international organizations that have objectives consistent with the goal of increasing the impact of the science of toxicology to improve public health” by

  • Strengthening partnerships among scientific- and health-based organizations to increase awareness of the impact of toxicology and related subjects on human health; and
  • Functioning as a means to enhance cooperation among societies as equals with the goal of accomplishing tasks benefitting human health and disease prevention through joint and several shared activities.

The Teratology Society is a member of the Scientific Liaison Coalition which affords Teratology Society members access to live and recorded SLC webinars.

 

 

 

 

 

Recent Stories
Free Webinar: The Veterinary Pathologist’s Role in the 3Rs, September 19 at 11 am ET

Press Release: Advances in 3-D Printing Launch a Promising Future for Birth Defects Treatments

Grant Opportunity: Advancing Actionable Alternatives to Vertebrate Animal Testing for Chemical Safety Assessment